Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

1.54
Delayed Data
As of Jun 24
 -0.13 / -7.78%
Today’s Change
1.23
Today|||52-Week Range
20.45
-84.75%
Year-to-Date

Today’s Trading

Previous close1.67
Today’s open1.57
Day’s range1.52 - 1.69
Volume3,046,851
Average volume (3 months)936,764
Market cap$47.8M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-88.89%
Earnings growth (this year)-45.98%
Earnings growth (next 5 years)+15.84%
Revenue growth (last year)+51.47%
P/E ratioNM
Price/Sales1.21
Price/Book0.41

Competitors

 Today’s
change
Today’s
% change
VSTMVerastem Inc-0.03-2.24%
PZRXPhaseRx Inc-0.60-12.90%
FATEFate Therapeutics In...+0.06+3.28%
CANFCan Fite Biopharma L...-0.07-2.62%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$239.9M
Annual profit (last year)-$73.3M
Net profit margin-30.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs